LEAP2
liver enriched antimicrobial peptide 2 | LEAP-2

This gene encodes a cysteine-rich cationic antimicrobial peptide that is expressed predominantly in the liver. The mature peptide has activity against gram-positive bacteria and yeasts. [provided by RefSeq, Sep 2014]

Biological processes 5 terms
Expression (TPM)
LEAP2 — as a Regulated Gene

TFs regulating LEAP2 0 TFs

Transcription factors with Perturb-seq knockdown data for LEAP2. The Binding column indicates whether any binding evidence exists for this TF–gene pair (ChIP-seq or motif footprint peaks). The Mean coef is the average Perturb-seq regression coefficient across active gRNAs (positive = LEAP2 upregulated upon KD; negative = downregulated). The Outlier column indicates whether this gene is in the top or bottom 5% of all TF knockdown effects.

Data: Effect:
TF Mean coef Binding Outlier TF→Gene link

Elements linked to LEAP2

Open chromatin peaks (ATAC-seq) in the genomic neighbourhood of LEAP2, linked by TSS proximity or chromatin conformation (Multiome / HiCAR). Each element overlaps at least one TF ChIP-seq binding site — the TFs column shows how many distinct TFs bind that element.

Accessibility Element Dist. to TSS Link type TFs
chr5:132,866,046–132,867,186 6.3 kb Proximal (<10kb) 955

Genome Browser

Genomic view of the LEAP2 locus showing ATAC-seq accessibility and RNA-seq expression across the ESC → DE time course, together with TF binding peaks and element-to-TSS loop connections.

chr5:132,856,046 – 132,877,186
Proximal 1 kb Distal 10 kb Multiome HiCAR ATAC-seq RNA-seq